Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
NASA's moon mission has begun — here's what's ahead for the Artemis II astronauts - 2Artemis 2 astronauts fly around the moon in record-breaking lunar loop by NASA
- 3Hamas set to elect new terror leader with Hayya, Mashaal in pole position
- 4Plane Passenger Allegedly Includes ‘Bomb Threat’ in Hotspot Network Name, Forces Flight to Make Emergency Landing
- 5Eleven Creations And Developments That Steered History
- Charlotte faith leaders hold interfaith forum on Black and Palestinian solidarity
- Progress Over Perfection: Lessons From Garment Factories Fighting Heat Stress
- Hundreds show fascist salute at rally in Rome in annual ritual
- CVS forecasts 2026 profit above estimates on strong performance
- The Main 15 Powerful Business Heads of Today
- Study reveals how fast weight returns after ending GLP-1 drugs
- Indoor Drinking Fountains: Famous Home Advancements during the Pandemic
- Palestinians forced from West Bank refugee camps left in limbo as Israeli demolitions go on
- Israel reports first missile fire from Yemen since start of Iran war
